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Background: Immunologic tolerance to tissue-restricted self-antigens primarily takes place in the thymus.
Results: Sequence variation within the Ica1 promoter is associated with increased autoimmune regulator (AIRE) binding and
transcription repression of ICA69 in medullary thymic epithelial cells.
Conclusion: AIRE is a transcription repressor within the NOD mouse Ica1 promoter.
Significance: A newly identified role for AIRE as a transcription repressor in medullary thymic epithelial cells.
ICA69 (islet cell autoantigen69kDa) is a protein implicated in
type 1 diabetes mellitus in both the non-obese diabetic (NOD)
mousemodel andhumans. ICA69 is encodedby the Ica1 geneon
mouse chromosome 6 A1-A2. We previously reported reduced
ICA69 expression in the thymus of NOD mice compared with
thymus of several non-diabetic mouse strains. We propose that
reduced thymic ICA69 expression could result from variations
in transcriptional regulation of the gene and that polymor-
phisms within the Ica1 core promoter may partially determine
this transcriptional variability. We characterized the functional
promoter of Ica1 in NODmice and compared it with the corre-
sponding portions of Ica1 in non-diabetic C57BL/6mice. Lucif-
erase reporter constructs demonstrated that the NOD Ica1 pro-
moter region exhibited markedly reduced luciferase expression
in transiently transfectedmedullary thymus epithelial (mTEC)
and B-cell (M12)-derived cell lines. However, in a non-diabetic
strain, C57BL/6, the Ica1 promoter regionwas transcriptionally
active when transiently transfected into the same cell lines. We
concomitantly identified five single nucleotide polymorphisms
within the NOD Ica1 promoter. One of these single nucleotide
polymorphisms increases the binding affinity for the transcrip-
tion factor AIRE (autoimmune regulator), which is highly
expressed in thymic epithelial cells, where it is known to play a
key role regulating self-antigen expression. We conclude that
polymorphisms within the NOD Ica1 core promoter may deter-
mine AIRE-mediated down-regulation of ICA69 expression in
medullary thymic epithelial cells, thus providing a novel mech-
anistic explanation for the loss of immunologic tolerance to this
self-antigen in autoimmunity.
Accumulating evidence indicates that organ-specific mole-
cules are naturally expressed in the thymus and peripheral
lymphoid organs (1, 2). Tolerance to tissue-restricted self-mol-
ecules is believed to begin in the thymus during maturation of
the immune system with the deletion of thymocytes exhibiting
strong affinity T-cell receptors towards self-molecules (3–5).
The insulin gene is one of themost widely studied genes in both
humans and mice, exhibiting thymic expression as well as a
-cell expression-dependent association with T1D3 suscepti-
bility (2, 6–9). For instance, in humans, the IDDM2 suscepti-
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bility locus of the insulin gene (INS) is a region associated with
T1D and has been finely mapped to reveal variable number of
tandem repeat (VNTR) polymorphisms upstream of the INS
promoter. The length of these repeats has been directly impli-
cated in the control of the expression levels of insulinmRNA in
the thymus (9–11). In addition to insulin, ICA69 (islet cell
autoantigen 69 kDa), a neuroendocrine protein targeted by
autoimmmune responses in human T1D and in non-obese dia-
betic (NOD)mice (12–14), is also expressed in the thymus, and
we considered the likelihood that thymic levels of ICA69would
affect susceptibility to T1D through a mechanism similar to
that shown for the insulin VNTRs (2, 15). This hypothesis is
primarily based on our previous studies indicating that IA-2,
GAD65, and ICA69 are transcribed in the human thymus
throughout fetal life and childhood (2, 10, 16). The significance
of thymic ICA69 expression in T1D susceptibility was rein-
forced through experiments involving tetracycline-responsive
transgene promoter studies in the NOD mouse model, which
exogenously overexpressed ICA69 in the thymus and spleen
(14). This overexpression of thymic ICA69 resulted in a signif-
icant delay of disease progression in this model (14).
Given that thymic ICA69 expression is significantly reduced
in NODmice compared with other non-diabetic mouse strains
(15), we now posit the existence of DNA sequence variation
with the potential for functionally relevant effects on Ica1 gene
expression in the thymus. Such variations in the Ica1 promoter
might lead to an increased probability of failure to negatively
select ICA69-reactive T-cell clones of developing thymocytes.
Therefore, sequence variations in the Ica1 promoter may
potentially affect tissue-restricted genes functionally involved
in autoimmunity and T1D. In the present study, we 1) establish
sequence variation in the Ica1 promoter of NOD and non-dia-
betic mice, 2) associate the variations with deficient expression
of ICA69 in a cell-based model, and 3) provide evidence for a
novel functional interaction of AIRE binding with Ica1 tran-
scriptional regulation.
EXPERIMENTAL PROCEDURES
Cell Lines—Medullary thymic epithelial cell line (mTEC)
positive for insulin productionwas kindly provided byDr. Con-
stantin Polychronakos (Endocrine Genetics Laboratory, Mon-
treal Children’s Hospital) and grown using completeMinimum
Essential Medium Eagle’s (MEM) following previously pub-
lished protocols (7). The mouse B-cell line (M12), generously
provided by Dr. Wesley Dunnick (University of Michigan, Ann
Arbor, MI), was propagated in RPMI 1640 complete medium
following previously published protocols (17).
Generation and Subcloning of Constructs—We have previ-
ously characterized the human ICA1 promoter region (18).
Based on our previous findings and DNA sequence similarity
with human ICA1, specific primers were designed for the puta-
tive mouse Ica1 promoter element as follows: 5 primer,
GAATTCTTATATTTTCATGTAATT; 3 primer, GAGTGT-
GAATTTCATAATCGTG. Due to the GC-rich nature of the
Ica1 promoter region, DNA samples were amplified for 35
cycles using the LA TaqTM PCR kit (Takara Mirus Bio, Madi-
son, WI) and corresponding buffers. Amplified PCR products
from NOD and C57BL/6 genomic DNA were directly sub-
cloned into the pCRII-TOPO vector (Original TA Cloning
Kit, Invitrogen) following themanufacturer’s protocol. Cloning
of Ica1 promoter elements was performed using the pGL3-Ba-
sic vector as described previously and later used in the lucifer-
ase assays (18). The pGL3 vectors containing the Ica1 promoter
elements were sequence-verified utilizing a series of overlap-
ping primer sets at the University of Michigan Sequencing
Core.
Luciferase Assays—Both mTEC and M12 cell lines were
assessed for luciferase reporter activity using the Dual-Lucifer-
ase reporter assay (Promega, Madison, WI). The protocol was
followed as described by the manufacturer for both cell lines
with the exception of a 30-min shaking incubation for the pas-
sive lysis step. Transfections were prepared as described below
for each respective cell line, and the luciferase assays were read
using the BDMonolight 3010 luminometer.
The mTEC cells were grown in 12-well plates in complete
MEM at a density of 0.9  105 cells/well 18 h prior to transient
transfection to ensure 70–80% confluence at the time of trans-
fection. ThemTEC cells were transfected in triplicatewith the
Luciferase pGL3-Ica1 constructs and the proper positive and
negative control vectors using the Fugene HD transfection rea-
gent (Roche Applied Science) at a ratio of 8:2 (8 l of reagent, 2
g of DNA).
M12 cells were plated in 24-well plates in complete RPMI
1640 medium at a density of 5.0  105 cells/well 18 h prior to
transfection. Luciferase pGL3-Ica1 constructs and the proper
positive and negative control vectors were transfected using
Effectene transcription reagent (Qiagen Inc., Valencia, CA) at a
ratio of 1:20 (DNA/Effectene).
The respective transfection reagent to pGL-3 Ica1DNAcon-
struct ratio was held constant for each tested construct for that
cell line described above. To allow for normalization of firefly
luciferase values based on transfection efficiency, the co-re-
porter vector pRL-TK expressing Renilla luciferase was
included in the transfection mixture at a ratio of 1:10 (co-re-
porter plasmid/experimental promoter construct) as reported
previously (18).
Mutagenesis—The pGL3-Basic vector containing the
C57BL/6 Ica1 sequence was used as the backbone to generate
three separate constructs by inserting different combinations of
multiple SNPs from the NOD Ica1 promoter sequence referred
to as Construct 1, Construct 2, and Construct 3. Construction
began with sequential digests of both the C57BL/6 and NOD
Ica1 sequences with restriction enzymes at 37 and 55 °C,
respectively. This was done to create a gap in the C57BL/6 Ica1
sequence into which a corresponding NOD Ica1 fragment
sequence containing specific SNPs would be inserted. Con-
struct 1 required the use of ZraI and BsmBI, such that the NOD
125-base pair fragment containing SNPs ()70 and ()117
were ligated into the C57BL/6 sequence between base pairs
1381 and 1506. Construct 2 required the use of SexAI and
BsmBI, such that the NOD 358-base pair fragment containing
SNPs at ()304, ()190, ()117, and ()70 were ligated into
the C57BL/6 sequence between base pairs 1144 and 1506. Con-
struct 3 required the use of enzymes Pm1I andBsmBI, such that
the NOD 506-base pair fragment containing SNPs ()471,
()304, ()190, ()117, and ()70 were ligated into the
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C57BL/6 sequence between base pairs 1000 and 1506. One
ShotTop 10 competent cells (Invitrogen)were transformed to
generate pure plasmid DNA preparations for use in the lucifer-
ase assays. All constructs were sequence-verified to contain the
appropriate SNPs utilizing overlapping primer sets at the Uni-
versity of Michigan Sequencing Core.
Isolation of mTEC Cells and Microarray Expression
Profiling—Isolation of thymic antigen presenting stromal cells
was performed as described previously (8). Briefly, thymi har-
vested from seven 5–6-week-old C57BL6/129 mice were nee-
dle-dissected into small pieces, collagenase-digested into single
cells, and negatively selected with anti-CD90 antibody-conju-
gated magnetic microbeads to deplete thymocytes (Miltyeni,
Auburn, CA). The stromal cells were separated further with an
anti-CD45microbead kit, followed by FACS intoCD45,MHC
II, CD11c macrophages and B-cells; CD45, MHC II,
CD11c thymic dendritic cells; CD45, EpCAM, UEA-1high,
Ly51low medullary thymic epithelial cells (mTECs); and
CD45, EpCAM, UEA-1low, Ly51high cortical thymic epithe-
lial cells.
Total RNA was isolated with the RNeasy microkit (Qiagen,
Valencia, CA), following the manufacturer’s procedures, and
reverse transcribed with the Superscript III cDNA synthesis kit
(Invitrogen). The following primers and conditions were used to
examine gene expression: Ica1, 5-TGAGTCTGCAACCTTCA-
ACAGGGA-3 and 5-AAACAGGGCCTTGACCCTCTCATT-
3, 40cycleswithLATaqpolymerase (TakaraMirusBio,Madison,
WI); cytokeratin 2/8 (K2-8), 5-AGGAGCTCATTCCGTAGCT-
G-3 and 5-TCTGGGATGCAGAACATGAG-3, 35 cycles with
TitaniumTaq (Clontech);Hprt, 5-GCGTCGTGATTAGCGAT-
GATGAAC-3 and 5-CCTCCCATCTCCTTCATGACATCT-
3, 35 cycles with Titanium Taq (Clontech, Mountain View, CA).
Insulin-expressing mTEC cells were isolated and grown as
described (37). Briefly, the cells were passaged at 33 °C and
grown in triplicate in 10-cm tissue culture dishes to 80–90%
confluence. RNAwas extracted using the RNeasy minikit (Qia-
gen, Mississauga, Canada) and treated with Ambion DNase I
(Ambion, Austin, TX), and 10 g from each of the triplicate
samples was applied to theAffymetrix (Santa Clara, CA)Mouse
Genome 430 2.0 arrays (containing 45,102 probe sets repre-
senting 39,000 transcripts).
Prior to microarray analysis, RNA quality was verified using
electrophoretic detection of the 18S and 28S peaks in anAgilent
2100 Bioanalyzer (Agilent, Colorado Springs, CO). Microarray
data were normalized using robust multiple-array averaging
(RMA), as log2 values. To determine the expression of a given
gene, relative to the rest of the transcriptome, its value was
placed on a frequency histogram of expression levels relative to
the rest of the genes on the array.
Identification of Transcription Factor Binding Sites—Tran-
scription factor binding site prediction was performed by
implementing the previously described PWM-Scan algorithm
(19). First, wemined theTransfac database (release 2010.1 from
Biobase) for 1,302 positional weight matrices (PWMs), each of
which corresponds to a transcription factor (TF) bindingmotif.
We then searched for high affinitymatches (p value of0.0001)
to these PWMs in the NODmouse Ica1 promoter region. This
p value threshold corresponds to an average expected fre-
quency of 1 match every 10 kb. We considered the identified
PWM matches as putative transcription factor binding sites.
We implemented this algorithm for both alleles at three
mutated loci positions: ()471 C/A; ()117 G/A; (70) G/A,
where the mutations correspond to the alleles in the wild type
genetic background of C57BL/6 mice (supplemental Table 1).
At eachmutant locus, we identified two classes of transcription
factor binding sites: 1) those that are predicted only with one
allele and 2) those that are predicted with both alleles but have
substantially different PWM affinity scores.
AIRE Binding Assay—Nuclear fractions of mTEC andM12
cells were prepared using the NE-PER nuclear and cytoplasmic
extraction kit and protocol (Pierce). The binding of AIRE in
nuclear extracts to the targeted sequence located at SNP
()471was determined using theNoShift transcription factor
assay kit and the corresponding protocol (Novagen Inc.,
Gibbstown, NJ). The oligonucleotide sequences are listed in
Table 1.
The specificity of AIRE TF binding to the NOD ()471 site
was determined utilizing a previously reported methodology
(20) and the NoShift protocol with the following exception.
The non-biotinylated competitor oligonucleotides for NOD
()471 and the C57BL/6 were used at 200 pmol per reaction, a
20:1 excess compared with the biotinylated NOD ()471. This
ratio is well within the range suggested in theNoShift protocol
for a 20-l reaction. The primary antibody was anti-mouse
AIRE (eBioscience, San Diego, CA) diluted 1:50, and the sec-
ondary antibodywas horseradish peroxidase (HRP)-conjugated
anti-rat IgG (Abcam, Cambridge, MA) diluted 1:1000. The
assays were performed in triplicate, and absorbance was meas-
ured using a PerkinElmer Life Sciences Victor3V 1420 multila-
bel plate reader.
Isolation of CD45 Stromal Cells from Lymph Nodes—
Lymph nodes (pancreatic, mesenteric, and axillary) were har-
vested from 3–4 NOD, C57BL/6, and B6.129S2-Airetm1.1Doi/J
(6–8 weeks old; Jackson Laboratory, Bar Harbor, ME) and
digested with collagenase. In this mouse, exon 2 and portions of
the flanking introns of theAire gene were deleted by Cre-lox-me-
diated homologous recombination. Analysis of the mutated Aire
transcript identified a frameshift that precludes translation past
exon 1. The separated single cells were negatively selected with
anti-CD45 antibody-conjugated magnetic beads (Miltenyi,
Auburn, CA), followed by positive selection with anti-MHC II
microbeads forMHCII, CD45 stromal cells. RT-PCRwas per-
formed according to previously publishedmethods (8).
Tissue Samples—Tissues from adult autopsy cases (spleen,
lymph nodes, and thymus) were provided by the Cell Trans-
TABLE 1
Biotinylated and unlabeled capture probes used to detect AIRE tran-
scription factor binding activity using the NoShift transcription factor
assay
The SNP is shown in capitalized boldface type at the putative recognition site.
Oligonucleotides Sequence (5–3)
NOD ()471 sensea Biotin-agataccctagaAatgggggtcacg
NOD ()471 antisensea Biotin-cgtgacccccatTtctagggtatct
NOD ()471 sense agataccctagaAatgggggtcacg
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plant Center, Diabetes Research Institute at the University of
Miami (21) and from the Department of Pathology of the Uni-
versity of Pittsburgh. From the available cases, 13 thymus, 25
spleen, and 3 lymph node specimens and 4 thymus, 2 spleen,
and 1 lymphnode specimenswere used for ICA69 staining. The
following tissues are from subjects whowere not known to have
T1D: thymus 1892: 2 days old, African American male; thymus
1897: 36 weeks old, Caucasian male; spleen and lymph node
2040, 40 weeks old, African American female; thymus and
spleen 2892: 24 weeks old, African American female; and thy-
mus 3222: 21 weeks old, African American female. All tissues
collected were obtained through the proper ethical and admin-
istrative procedures of both institutions.
Immunohistochemistry—Human thymus tissue sections (6
m) were fixed in paraformaldehyde (4% in phosphate-buff-
ered saline, pH 7.4) and then paraffin-embedded according to
previously published protocols (15, 21). Human spleen and
lymph node frozen sections (5 m) were fixed in 2% buffered
formalin. Mouse anti-human ICA69 antibody was generated in
our laboratory from the hybridoma, IA-A564. The primary
antibodywas used at a dilution of 1:50 for both paraffin-embed-
ded and frozen tissues. Negative controls included omission of
the primary antibody and incubation with an isotype control
antibody as primary antibody. Human thymus tissues were
stained using the LSAB kit (Dako, Carpinteria, CA) according
to the manufacturer’s protocol with the addition of a mild per-
meabilization method prior to the application of the primary
antibody (22). Slides were then counterstained with Gill’s
hematoxylin solution. Human spleen and lymph node prepara-
tions were stained using the streptavidin-biotin-peroxidase
method and aminoethylcarbazole (red) as substrate for the
horseradish peroxidase enzyme (Zymed Laboratories Inc., San
Francisco, CA).
Isolation of RNA and Detection of ICA69 in Mouse Thymic
Tissue—Thymus tissue was harvested from three 5-week-old
female C57BL/6 and NOD mice and homogenized in TRIzol
according to the manufacturer’s protocol (Invitrogen) to gen-
erate total RNA.We used standard cDNA two-step processing
using theMaloney murine leukemia virus reverse transcriptase
(Epicenter,Madison,WI) according to themanufacturer’s pro-
tocol. The cDNA was then generated from total RNA for each
strain to be used for PCR analysis.
The PCRs each contained 5 l of cDNA, 1 l of LA Taq
(Takara Mirus Bio, Madison, WI), including primers in a total
reaction volumeof 50l. Thirty cycleswere completed at 94 °C,
denaturation for 30 s, 58 °C annealing for 30 s, and 72 °C elon-
gation for 45 s. Primers used were mICA69Fr (CACCATGT-
CAGGACACAAATGTTATTCCTGGGAG) and mICA69Rv
(GTTCACTGTCAGCCAGGTATCAGAGATGGC). Amplifi-
cation using a primer set specific for glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was carried out to test the
integrity of the cDNA using theMouse GAPDH Primer Set Kit
(Maxim Biotech, Inc. Rockville, MD) (data not shown). The
ICA69-generated PCR fragment was gel-purified, and the
nucleotide sequence was verified using overlapping primer sets
at the University of Michigan Sequencing Core.
Statistical Analysis—Results were reported as the mean 
S.E. of replicates described throughout. Luciferase assay and
AIRE binding assay values between groups were compared
using theMann-Whitney test. p values less than 0.05 were con-
sidered significant.
RESULTS
Expression of ICA69 in Human Thymus and Peripheral
Lymphoid Organs—We have previously reported that ICA69
transcripts were detected by RT-PCR in human thymi at differ-
ent stages of maturation (both fetal and postnatal tissues) (2).
We now show that an ICA69 mAb can detect the protein
expressed in human thymus tissue sections (Fig. 1). Fig. 1A
illustrates the presence of ICA69-positive stained cells found
predominantlywithin the thymicmedulla region of human thy-
mus paraffin sections. The antibody specific staining of these
cells, as shown in Fig. 1B, disappears after the ICA69 mAb is
absorbed with the recombinant ICA69 protein prior to the
staining procedure. Additionally, there was no staining when a
control isotype antibody was used with or without the second-
ary antibody (data not shown). ICA69-positive cells were also
detected in human spleen and lymph node frozen sections
shown in Fig. 1, C and D, respectively. The proportion of cells
that stained positive for ICA69 ranged from 1 to 3% in most
evaluated sections.
Ica1 Is Predominantly Expressed in mTEC within Thymus—
Our previous studies with both human and mouse tissues (2, 15)
were further expanded throughFACSof thymocytes andmicroar-
ray expression profile examination, whether or not there was sig-
nificant expression of ICA69 in insulin-expressingmedullary thy-
mic epithelial cells. Mouse thymi from C57Bl6/129 mice were
harvested, digestedwith collagenase, and separated into four stro-
mal populations via magnetic beads and FACS, as described pre-
viously (8).Thecell populationCD45, EpCAM,UEA-1high, and
Ly51low (mTECs) in Fig. 2A, lane R3, shows evidence that Ica1
expression is found predominantly in the medullary thymic epi-
thelial cells. It is well known that this same subpopulation ofmed-
ullary thymic epithelial cells (CD45, EpCAM, UEA-1high,
Ly51low) expressAIRE in addition to a specific pattern of costimu-
latorymolecules, including CD40, CD80, and PD-L1 (23, 24). The
results, shown in Fig. 2B, indicate a biologically significant expres-
sion of Ica1 in the microarray profiling of an insulin-expressing
medullary thymic epithelial (mTEC) cell line. To determine the
expressionof a givengene, relative to the rest of the transcriptome,
its value was placed on a frequency histogram in relation to the
expression levels of other genes in the array. Ica1 gene expression
is found to be within the 64th percentile relative to the expression
of the rest of the transcriptome.
Characterization of Ica1 Core Promoter Elements—We iden-
tified the 5-flanking region of the mouse Ica1 gene (Gen-
BankTM accession number JF513202) by initially examining the
degree of homology between the human ICA1 promoter (18)
and the corresponding mouse nucleic acid sequences available
in the NCBI GenBankTM data base. Homology searches of
nucleic acid sequences revealed an 85% identity between the
human and the putative mouse promoter core sequence of the
Ica1 gene, which maps on chromosome 6 A1-A2. Based on this
high degree of nucleotide sequence similarity, we designed spe-
cific oligonucleotides and amplified a 2.6-kb genomic DNA
PCR product from bothNOD and C57BL/6mouse strains. The
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resulting gel-purified or undiluted PCR products were subse-
quently subcloned into the pCRII-TOPO vector (18) and
sequenced. Given the high degree of similarity with the human
ICA1 promoter (18), we have termed the Ica1 5-UTR exon
sequences exons A, B, and C rather than adopt the 3, 2, 1
exon notation proposed by Gaedigk et al. (25). We have
adopted this notation to maintain consistency with our previ-
ous studies of the human ICA1 promoter (18) and for ease in
recognition of the sequence similarity of the mouse Ica1 pro-
moter. The Ica1 promoter sequence is summarized as an illus-
tration in Figs. 3 and 4.
We then began to consider putative functional characteris-
tics of the Ica1 5-regulatory elements. Similar to the ICA1 pro-
moter (18), initiation of Ica1 transcription was found to origi-
nate from any one of three distinct 5-untranslated exons with
independent transcription initiation signals characteristic of
non-TATA, non-CCAAT, or GC-rich promoters. Remarkably,
we found that almost all potential transcription activator
sequences and TF binding sites were identical to those found in
the human ICA1 promoter (Figs. 3 and 4). Surrounding the
putative transcription initiation site(s) are motifs characteristic
of consensus Sp1/Sp3/GC-boxes and cAMP-responsive ele-
ment-binding protein sites. In order to determine if these dif-
ferences in transcriptional activity were due to cis-acting vari-
ations, we aligned the two 2.6-kb genomic DNA sequences
from NOD and C57BL/6 mice and found that the NODmouse
Ica1 promoter exhibited five unique nucleotide differences,
SNPs, comparedwith theC57BL/6 Ica1 promoter. Thesenucle-
otide differences are specific to the NOD strain and are not found
in the other non-diabetes disease-prone mouse strains exam-
ined, includingC57BL/6, Balb/c, and SWR.The five SNPs iden-
tifiedwithin the Ica1 core promoter region arewithin 1) exonA
at ()471, ()304, and ()190; 2) exonB at ()117; and 3) exon
C at ()70 (Fig. 3).
Functional Impact of NOD Ica1 Promoter Elements on Gene
Expression—To determine the functional effects of these
SNPs on promoter activity, we first generated a number of
reporter gene constructs whereby Ica1 promoter sequences
were fused to the luciferase gene. The functional role of the
5-flanking region in the regulation of transcription of the
Ica1 gene was assessed by its ability to direct expression of
the luciferase gene in a transient transfection assay format
using mTEC cells, derived from NOD mouse thymus (7),
and a mouse B cell line (M12) (17). A 2.6-kb fragment of the
C57BL/6 5-flanking region of the Ica1 gene was inserted
into the luciferase reporter gene pGL3-Basic. This construct
exhibited significant luciferase activity when transiently
transfected into mTEC and M12 cells (Fig. 5, B and C,
respectively). In multiple transfection experiments, the rel-
ative expression of luciferase using the pGL3-C57BL/6 pro-
moter expression vector was consistently 10–20-fold greater
than the background measured with the pGL3-Basic pro-
moterless vector. Hence, we conclude that the 5-flanking
region of the Ica1 gene has promoter activity. When using
constructs of the corresponding 2.6-kb fragment of the NOD
5-flanking region of the Ica1 gene containing the identified
SNPs, the reporter activity was markedly reduced in both
FIGURE 1. ICA69 autoantigen expression in the human thymus (A and B), spleen (C), and lymph node (D) denoted with arrows. A, a microphotograph of
ICA69 using the ICA69 mAb and alkaline phosphatase immunoenzymatic detection. Staining of a paraformaldehyde-fixed section of human thymus with the
ICA69 mAb shows selective staining for a cell subtype that is present predominantly in the medulla (200). B, ICA69-specific staining disappears after
absorbing out the ICA69 mAb with the recombinant human ICA69 molecule against which this mAb was produced (200). C and D, immunostaining of spleen
(400) and lymph node (200) frozen sections after incubation with the ICA69 mAb detected with the streptavidin-biotin-peroxidase method and the
aminoethylcarbazole substrate (red) and counterstaining with hematoxylin.
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mTEC and M12 cells compared with that of the non-dia-
betic C57BL/6 construct (Fig. 5; p  0.01).
We next investigated the functional significance of the five
SNPs identified in the NOD Ica1 by transient transfection
experiments in the mTEC and M12 cell lines. Three con-
structs were generated to analyze different combinations of
multiple SNPs from the NOD Ica1 core promoter when
inserted into the wild type promoter backbone of the
C57BL/6 (Fig. 5A). This analysis revealed that the NOD-
specific SNPs were associated with a reduced expression in
luciferase activity in both mTEC and M12 cells when com-
paring the mutated C57BL/6 core promoter sequence con-
taining all five NOD SNPs (Construct 3) to the normal
C57BL/6 core promoter sequence (Fig. 5, B and C). The
results of the luciferase assays involving four of the five indi-
vidually mutated SNPs within the NOD putative Ica1 pro-
moter region did not result in significant changes in tran-
scriptional activity (data not shown).
FIGURE 2. A, reverse transcriptase PCR analysis of thymic Ica1 gene expression. Thymi from C57Bl6/129 mice were harvested, digested with collagenase, and
separated into four stromal populations via magnetic technology and FACS sorting, as described previously (8). R1, CD45, MHC II, CD11c macrophages,
and B-cells; R2, CD45, MHC II, CD11c thymic dendritic cells; R3, CD45, EpCAM, UEA-1high, Ly51low mTECs; R4, CD45, EpCAM, UEA-1low, Ly51high cortical
thymic epithelial cells; Thy, whole thymus. K-2-8, epithelial cell marker cytokeratin 2/8; Hprt, housekeeping gene hypoxanthine-guanine phosphoribosyltrans-
ferase as control. As shown, Ica1 is predominantly expressed in mTECs within the thymus. B, expression levels of Ica1 in the microarray profiling of an
insulin-expressing mTEC cell line, in relation to a frequency histogram of expression levels of all probes in the microarray. Ica1 is on the 64th percentile relative
to the rest of the transcriptome.
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To further our analysis of the promoter, we performed in
silico TF binding site analysis and identified several TFs pre-
dicted to have allele-specific binding activity at each of the three
polymorphic loci in the NOD mouse Ica1 promoter region
(supplemental Table 1). The TFs with the strongest differential
binding affinities between alleles are as follows: BCL6 andAIRE
at 471 (A/C); E2F1 at 117 (A/G); and PAX4 at 70 (A/G).
Many TFs serve as either activators or repressors of gene
expression, depending on the cellular context; therefore, the
functional consequence of the predicted allele-dependent TF
binding affinity was not immediately evident and requires fur-
ther molecular investigation.
The AIRE transcription factor is highly expressed in the
thymus and in extrathymic AIRE-expressing cells (26),
wherein it is a critical element in the induction of immuno-
logical tolerance (27). To validate the predicted AIRE bind-
ing site at position 471 in the NOD Ica1 promoter, we used
the NoShift assay. Using mTEC and M12 nuclear cell
extracts, the binding of AIRE to oligonucleotides containing
the predicted AIRE binding site (NOD) was stronger relative
to oligonucleotides without the AIRE binding site (C57BL/6)
(Fig. 6A; mTEC, p  0.02; M12 cells, p  0.01). To support
our in vitro studies, we provide additional in vivo evidence
demonstrating that Ica1 expression of ICA69 is more highly
expressed in CD45 MHC class II stromal cells (CD45,
EpCAM, UEA-1high, Ly51low) isolated from lymph nodes
from Aire-deficient mice as compared with the same cell
subpopulation obtained from C57BL/6 and NOD mice (Fig.
6B; p  0.001). Finally, subsequent PCR analysis, using
cDNA generated from thymic tissue, showed that expression
of ICA69 is significantly reduced in NOD when compared
with C57BL/6 (Fig. 6C).
DISCUSSION
ICA69, a protein product of human ICA1ormouse Ica1 (12, 18,
28, 29), is predominantly expressed in the islets of Langerhans and
neuroendocrine organs (12, 13). This protein and its Caenorhab-
ditis elegans homologue, ric-19 are conserved regulators of neu-
roendocrine secretion (30). ICA69 is involved indense core vesicle
signalingandmaturation (31)and is recruited toGolgimembranes
byactivatedRAB-2 (32). ICA69 is thought tobeaT1Dautoantigen
based on the following observations: 1) autoantibodies to ICA69
can be detected in both first degree relatives of T1D patients who
are followed to overt diabetes and in newly diagnosed diabetic
patients (12, 14, 33–35); 2) autoreactive T cells directed to ICA69
can be detected in (a) newly diagnosed diabetic children (80%of
patients with recent onset T1D have either ICA69 autoreactive T
cells or autoantibodies against the molecule) (29) and (b) NOD
mice (36, 37); and 3) T cells specific for themurine ICA69 peptide
Tep-69 play a driving role in the acceleration of T cell-mediated
islet cell destruction in NODmice, whereas intraperitoneal injec-
tion of the peptide Tep-69 is associated with decreased T1D inci-
dence inNODmice, apparently as a result of neonatal tolerization
of unknownmechanism (38). The latter studies are promising and
are based on the generation of a NOD mouse T cell hybridoma
that recognizes the murine peptide Tep69. Adoptive transfer
models of diabetes development were utilized to test the func-
tional significance of the Tep69-specific T cells in NOD mice;
intravenous administration of Tep69 peptide into adoptive trans-
fer recipients dramatically accelerated the development of diabe-
tes inNODmice (36).Moreover, in recombinant congenic strains,
which share 85% of the NOD mouse genome, the presence of
CBA/LsLtgenome(diabetes-resistant strain) in theregionofchro-
mosome6where the Ica1gene is localized results inmice resistant
to both spontaneous insulin-dependent diabetes and cyclophos-
phamide-induceddiabetes (39).More recently, association studies
in systemic lupus erythematosus identified ICA1 as one of the sus-
ceptible genetic candidates for this condition, supporting the
notion that some common pathways are shared with a number of
autoimmune disorders (40, 41).
For the first time, we have characterized the mouse putative
Ica1 promoter elements of C57BL/6 and NOD mouse strains.
Our approach to analyzing the Ica1 5-flanking sequences for
promoter activity was assisted, in part, by alignment with the
human ICA1 promoter and by computer analysis of the flank-
ing sequences for potential transcription activator sequences
and TF binding sites. There is a high degree of identity between
the mouse Ica1 and human ICA1 core promoters (18). We fur-
ther show that the Ica1 promoter region is polymorphic
(namely there are five SNPs distinguishing the NOD from the
C57BL/6 sequence) and that the NOD-derived Ica1 promoter
exhibits markedly reduced reporter activity in both mTEC
and M12 cells compared with the C57BL/6-derived promoter.
Although mutagenesis of the C57BL/6-derived promoter at
four of five individual SNP loci did not reduce reporter activity,
the insertion of multiple SNPs did, suggesting that the SNPs
may have a combined effect.
Despite the paucity of data on the mechanism of ICA69-
based tolerance induction in NOD neonatal mice, our results
support the existence of more fundamental means of autoreac-
FIGURE 3. Nucleic acid sequence of the NOD/ShiLtJ strain Ica1 promoter
elements; GenBankTM accession number JF513202. By alignment analysis
and comparison with human ICA1 promoter sequence, the entire sequence of
the mouse putative Ica1 promoter and flanking regions was confirmed. The
nucleotide sequence shows potential transcription activator sequences and
binding sites for TFs. Exon sequences are shown in capital letters. Intronic
sequences are shown in lowercase letters, and the consensus initiator (Inr)
sequence for exon A and exons B and C is illustrated. The five SNPs, ()471
(C/A), ()304 (G/A), ()190 (G/C), ()117 (G/A), and ()70 (G/A), within the
NOD Ica1 core promoter sequence are underlined.
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tivity control based on the expression of this putative autoanti-
gen in the thymus, whereby Ica1 transcription levels may be
under the direct effects of promoter sequence variants. Our
previous findings indicated that thymic expression of ICA69 is
reduced in NOD as compared with a number of control mice
(15). Although these experiments do not provide definitive evi-
dence to a precise molecular mechanism to account for this
observation, they do imply that either the polymorphic Ica1
NOD promoter, or a haplotype in linkage disequilibrium with
it, may modulate Ica1 promoter activity of the thymus which is
believed to be intrinsic to T1D susceptibility. The resulting
reduction in thymic expression of ICA69 in the NOD mouse
might contribute to the loss of immunologic tolerance in this
model of autoimmune diabetes.
Genetic variations resulting in defective thymic expression of
islet cell autoantigens have been implicated in the loss of immu-
nologic tolerance to these autoantigens. Functional variation of
INS promoter conferred by the VNTR polymorphism has been
associatedwith reduced insulin expression in the thymus and in
lymphoid organs (42, 43). Another example is provided by the
autoimmune polyendocrine syndrome type I, which is a mono-
genic disease caused by mutations within the AIRE locus (44).
Of note, AIRE-deficient mice develop a multiorgan autoimmu-
nity characterized by lymphocytic infiltrates and autoantibod-
ies, resembling those abnormalities seen in autoimmune poly-
endocrine syndrome type I, along with a specific reduction in
ectopic transcription of genes encoding peripheral self-anti-
gens (45, 46). In the present study, we demonstrate that a newly
identified polymorphic Ica1 promotermay account for reduced
expression of ICA69 in the thymus of NOD mice, which may
play a role in T1D susceptibility.
Interestingly, luciferase reporter constructs demonstrated
that the C57BL/6 Ica1 promoter region was transcriptionally
active not only in mTEC but also in M12 B-cell-derived cell
lines (17). B cell antigen capture and presentation, associated
with determinant antigen spreading, has become a very popular
concept since the previously reported results of the rituximab
treatment in NOD mice and in human T1D showing delay in
disease progression as a result of transient B cell depletion
(47–49).
FIGURE 4. Significant sequence identity is shared between the NOD mouse Ica1 promoter and the human ICA1 promoter. The alignment of major
elements, including exons A, B, and C along with the intron sequences in close proximity of the NOD mouse Ica1 and human ICA1 promoters, shows
considerable identity. A, exon A and the close flanking intron sequence show 79% identity between humans (h) and mice (m). In addition, the potential
transcription activator sequences and TF binding sites show an even higher sequence identity. B, both exons B and C show 82% sequence identity between
humans and mice. Remarkably, the sequence identity in the potential transcription activator sequences and TF binding sites is 100%.
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Our study predicts several TFs that have allele-specific binding
at each of threemutant loci in the Ica1 promoter region. It is pos-
sible that the loss/gain of one or more of these TF binding events
FIGURE 5. A, schematic representation of three constructs with mutations within
the Ica1 core promoter that were utilized in luciferase assays. Different combina-
tions of SNPs from the Ica1 promoter NOD strain were inserted into the wild type
promoter backbone (C57BL/6). B, mTEC cells were transiently transfected with
putative Ica1 promoter element constructs or pGL3-Basic reporter vector posi-
tive and negative controls. The transcriptional activity driven by the putative Ica1
promoter element inserted within its promoter site of pGL3-Basic reporter vector
was assessed by luciferase activity. The luciferase assay showed an approximately
8-fold reduction of enzyme and transcription activity from the NOD Ica1 putative
promoter element as compared with the C57BL/6 putative Ica1 promoter (*, p 
0.01). Mutated SNPs found in the NOD promoter element also illustrate reduced
enzyme and transcriptional activity. Results are expressed as mean  S.E. (error
bars) of 5–7 independent sets of transfection experiments performed in triplicate.
C, M12 cells were transiently transfected with putative Ica1 promoter element
constructs or pGL3-Basic reporter vector positive and negative controls. The tran-
scriptional activity driven by the putative Ica1 promoter element inserted within
the promoter site for the pGL3 reporter was assessed by luciferase. The luciferase
assay shows a 20-fold reduction of enzyme and transcription activity for the NOD
Ica1 putative promoter element as compared with the C57BL/6 putative Ica1
promoter (*, p  0.01). Mutated SNPs found in the NOD promoter element also
showed reduced enzyme and transcriptional activity. Results are expressed as
mean  S.E. of 5–7 independent sets of transfection experiments performed in
triplicate.
FIGURE 6. AIRE TF binding to the NOD Ica1 core promoter and Ica1
expression. A, nuclear extracts containing the AIRE TF were incubated
with double-stranded oligonucleotides (Table 1) to determine the AIRE
binding specificity for the NOD SNP at base pair ()471 of the Ica1 pro-
moter. Binding to oligonucleotides containing the NOD single AIRE TF
binding site was substantially greater than that of the C57BL/6 oligonu-
cleotide (lacking the AIRE TF binding site) with nuclear proteins from both
mTEC (*, p  0.02) and M12 cells (**, p  0.01). Specificity for the NOD
()471 SNP is shown in columns whereby the non-biotinylated C57BL/6
oligonucleotide does not compete out for the biotinylated NOD ()471
oligonucleotide, whereas the non-biotinylated NOD ()471 does com-
pete. The data are reported as the mean  S.E. of three independent
triplicates. B, high ICA69 expression in lymph node stromal cells of AIRE-
deficient mice. CD45 MHC II lymphoid stromal cells were isolated from
NOD, C57BL/6, and AIRE-deficient mice (B6.129S2-Airetm1.1Doi/J) and were
subjected to quantitative RT-PCR analysis of ICA69 expression. Data are
presented as arbitrary units relative to hprt controls (mean  S.E. (error
bars), n  3 C57BL/6 and n  3 AIRE-deficient mice; ***, p  0.001). C,
amplification of a 500-base pair fragment of Ica1 from cDNA generated
from C57BL/6 thymic tissue. A 500-bp specific band is present only for the
C57BL/6. This PCR fragment was gel-purified, and nucleotide sequence
was verified.
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may contribute to the observed differences in the activity of the
mutant Ica1 promoter. Encouragingly, a number of the TFs iden-
tified are key regulators of processes relevant to Ica1 gene function
and autoimmunity (e.g. BCL6 (50) and AIRE (51)).
The TF AIRE controls the expression of a set of tissue-spe-
cific antigens in medullary thymic epithelial cells whereby self-
reactive T cells undergo negative selection (52, 53). Autoim-
mune disease ensuing from a loss of self-tolerance is clinically
and genetically complex and has many potential etiological
causes. Evidence indicates that it is commonly linked to defects
in the thymic epithelial and lymphoid microenvironment.
We found that that ICA69 is more highly expressed in stro-
mal cells (CD45 MHC class II) isolated from lymph nodes
from AIRE-deficient mice as compared with the same cell sub-
population obtained fromB6mice. Hence, our findings suggest
that AIRE may be directly involved in controlling the expres-
sion of ICA69 in mTEC and in extrathymic AIRE-expressing
cells. Furthermore, our results provide experimental evidence
for preferential binding of AIRE to the NOD mouse Ica1 pro-
moter, where it functions as a transcriptional repressor, thereby
down-regulating ICA69 expression.
Previous analyses of gene expression patterns in AIRE-defi-
cient mice indicate that AIRE may function as either a tran-
scriptional activator or a repressor, depending on the promoter
context (51, 54). It has been found that AIRE can act as a tran-
scriptional repressor on the promoter of the housekeeping gene
encoding cystatin B (51). The effects of AIRE on different gene
promoters are modulated by interactions with other transcrip-
tional regulators, such as PIAS1, but might also depend on
DNA elements or the chromatin structure of the specific pro-
moter (51, 55).
In summary, this is the first report describing the mouse Ica1
core promoter DNA sequence providing evidence that SNPs
within this region are unique and functionally distinguishable
between the diabetes-prone NOD mouse and the control
C57BL/6 mouse strain. These SNPs provide potential functional
relevance to the development of autoimmunity, whichmay trans-
late into similar effects in human disease. This variation may be
functionally linked to reduced thymic expression of ICA69 sec-
ondary to AIRE-mediated down-regulation of ICA69 expression
and be directly involved in thymus-specific processes of negative
selection of ICA69-reactive developing thymocytes. Altogether,
Ica1 may be an additional gene involved in the maintenance of
central tolerance to  cell-restricted antigens, and deciphering its
expressionmechanisms in vivowill lead to amore comprehensive
understanding of the role of the thymus and other lymphoid
organs in islet autoimmunity.
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